Prevalence of and Potential Influencing Factors for Alcohol Dependence in EuropeRehm J.a-f · Anderson P.g, h · Barry J.i · Dimitrov P.j · Elekes Z.k · Feijão F.l · Frick U.m · Gual A.n · Gmel, Jr. G.a,o,p · Kraus L.q, r · Marmet S.s · Raninen J.t-v · Rehm M.X.w · Scafato E.x · Shield K.D.a,d,f · Trapencieris M.y · Gmel G.s,z,aa
aSocial and Epidemiological Research (SER) Department, Centre for Addiction and Mental Health, bAddiction Policy, Dalla Lana School of Public Health, University of Toronto, cDepartment of Psychiatry, Faculty of Medicine, University of Toronto, and dPAHO/WHO Collaborating Centre for Mental Health and Addiction, Toronto, Ont., Canada; eEpidemiological Research Unit, Klinische Psychologie und Psychotherapie, Technische Universität Dresden, Dresden, Germany; fInstitute of Medical Science, University of Toronto, Toronto, Ont., Canada; gInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, UK; hFaculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands; iTrinity College, Dublin, Ireland; jNational Center of Public Health and Analyses, Sofia, Bulgaria; kCorvinus University of Budapest, Budapest, Hungary; lGeneral-Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD), Lisbon, Portugal; mHSD University of Applied Sciences, Cologne, Germany; nAddictions Unit, Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, Barcelona, Spain; oSchool of Electrical Engineering and Telecommunications, The University of New South Wales, Kensington, N.S.W., and pNational Information and Communications Technology Australia, Eveleigh, N.S.W., Australia; qIFT Institut für Therapieforschung, Munich, Germany; rCentre for Social Research on Alcohol and Drugs, Stockholm University (SORAD), Stockholm, Sweden; sAddiction Switzerland, Lausanne, Switzerland; tSTAD-project (Stockholm Prevents Alcohol and Drug Problems), uSwedish Council for Information on Alcohol and Other Drugs (CAN), and vDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; wGraduate School of International Relations, Ritsumeikan University, Kyoto, Japan; xNational Observatory on Alcohol, Population's Health and Health Determinants Units, National Centre for Epidemiology, Surveillance and Health Promotion - CNESPS, Istituto Superiore di Sanita, Rome, Italy; yInstitute of Philosophy and Sociology, University of Latvia, Riga, Latvia; zUniversity of the West of England, Bristol, UK; aaAlcohol Treatment Center, Lausanne, University Hospital, Lausanne, Switzerland
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Alcohol use disorders (AUDs), and alcohol dependence (AD) in particular, are prevalent and associated with a large burden of disability and mortality. The aim of this study was to estimate prevalence of AD in the European Union (EU), Iceland, Norway, and Switzerland for the year 2010, and to investigate potential influencing factors. The 1-year prevalence of AD in the EU was estimated at 3.4% among people 18-64 years of age in Europe (women 1.7%, men 5.2%), resulting in close to 11 million affected people. Taking into account all people of all ages, AD, abuse and harmful use resulted in an estimate of 23 million affected people. Prevalence of AD varied widely between European countries, and was significantly impacted by drinking cultures and social norms. Correlations with level of drinking and other drinking variables and with major known outcomes of heavy drinking, such as liver cirrhosis or injury, were moderate. These results suggest a need to rethink the definition of AUDs.
© 2014 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.